Early Development and Durability of SARS-CoV-2 Antibodies Among Solid Organ Transplant Recipients: A Pilot Study

Transplantation. 2021 May 1;105(5):e52-e53. doi: 10.1097/TP.0000000000003637.

Authors

Brian J Boyarsky¹, Michael T Ou¹, William A Werbel², Robin K Avery², William A Clarke³, Aaron A R Tobian³, Allan B Massie¹, Dorry L Segev¹, Jacqueline M Garonzik Wang¹

Affiliations

¹ Department of Surgery, Johns Hopkins University School of Medicine, Baltimore, MD.
² Department of Medicine, Johns Hopkins University School of Medicine, Baltimore, MD.
³ Department of Pathology, Johns Hopkins School of Medicine, Baltimore, MD.

No abstract available

Publication types

Research Support, N.I.H., Extramural
Research Support, Non-U.S. Gov't

MeSH terms

Adult
Antibodies, Viral / chemistry*
COVID-19 / complications*
COVID-19 / immunology*
Electronic Health Records
Female
Humans
Immune System
Immunosuppressive Agents / therapeutic use
Male
Middle Aged
Organ Transplantation*
Pilot Projects
SARS-CoV-2
Transplant Recipients*

Substances

Antibodies, Viral
Immunosuppressive Agents

Grants and funding